275 results on '"Blaszkewicz, M."'
Search Results
2. Exposure of infants to ochratoxin A with breast milk
Catalog
Books, media, physical & digital resources
3. Acute Experimental Exposures to Acetone and Ethyl Acetate
4. N-Acetyltransferase 2: ultra-slow acetylators enter the stage
5. Coupling of HPLC and Chemical Reaction Detectors for Trace Analysis of Alkyllead Species
6. Primary rat hepatocytes as in vitro system for gene expression studies: comparison of sandwich, Matrigel and 2D cultures
7. Biomonitoring of ochratoxin A in grain workers
8. Ochratoxin A blood concentration in healthy subjects and bladder cancer cases from Pakistan
9. Pilotstudie zum Biomonitoring für Ochratoxin A bei Beschäftigten im Getreide-und Rohkaffee-Umschlag
10. Interlaboratory comparison to evaluate a standardized calibration procedure for the headspace analysis of aromatic solvents in blood
11. Fractionation of nickel species from airborne aerosols: practical improvements and industrial applications
12. Untersuchung zur klinischen Relevanz der Acetyliererphänotypisierung bei 196 Urotheltumorpatienten
13. GENETISCHE DETERMINATION DER MELATONINPRODUKTION: 63(S)
14. ACETYLATOR PHENOTYPE AND PROGNOSIS 1N UROTHELIAL BLADDER CANCER PATIENTS: P7-1
15. Krankheitsverlauf bei Harnblasenkarzinompatienten mit angezeigtem Verdacht auf Vorliegen einer Berufskrankheit und fremdstoffmetabolisierende Enzyme
16. Ultra-langsamer N-Acetyltransferase 2 (NAT2) Genotyp und rezidiv-freies Überleben von Harnblasenkrebspatienten
17. 364 Urinary bladder cancer in a former area of coal, iron and steel industries in germany
18. 367 Prognosis of occupational bladder cancer and polymorphic xenobiotic metabolising enzymes
19. Interaktion von vier genetischen Risikovarianten für das Harnblasenkarzinom
20. Einfluss eines Risiko-Scores auf der Basis genetischer Polymorphismen für das rezidiv-freie Überleben bei Harnblasenkarzinompatienten
21. Einfluss des N-Acetyltransferase 1*10 Genotyps auf das Harnblasenkarzinomerkrankungsrisiko
22. Risikofaktoren für das Harnblasenkarzinom an einem ehemaligen Standort der Montanindustrie
23. Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer
24. Krankheitsverlauf bei Harnblasenkarzinompatienten mit angezeigtem Verdacht auf Vorliegen einer Berufskrankheit und fremdstoffmetabolisierende Enzyme
25. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry
26. Einfluss des N-Acetyltransferase 1*10 Genotyps auf das Harnblasenkarzinomerkrankungsrisiko
27. Genotypen polymorpher fremdstoffmetabolisierender Enzyme bei Harnblasenkarzinompatienten in Budapest
28. Absract
29. Occurrence of aflatoxin M1 in urines from rural and urban residents in Bangladesh
30. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer
31. Population toxicokinetics of ethylene - Calibration and preceding investigations
32. Population toxicokinetics of ethylene: Calibration and preceding investigations
33. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.
34. Exposure of infants to ochratoxin A with breast milk
35. Bisphenol A, genistein, daidzein and equol in urine [Biomonitoring Methods, 2013]
36. Tetrahydrofuran (THF) in urine (Addendum to the DFG method “Alcohols and Ketones”) [Biomonitoring Methods, 2013]
37. Bisphenol A, Genistein, Daidzein und Equol in Urin [Biomonitoring Methods in German language, 2012]
38. Tetrahydrofuran (THF) in Urin - Addendum zur DFG-Methode “Alkohole und Ketone” [Biomonitoring Methods in German language, 2012]
39. N-Acetyltransferase 2 (phenotyping: caffeine test) [Biomonitoring Methods, 2004]
40. Kreatinin in Urin [Biomonitoring Methods in German language, 2010]
41. N-Acetyltransferase 2 (genotyping) [Biomonitoring Methods, 2004]
42. Ochratoxin A [Biomonitoring Methods, 2010]
43. High performance liquid chromatographic methods for the determination of organic substances in biological materials [Biomonitoring Methods, 2000]
44. Ochratoxin A [Biomonitoring Methods in German language, 2010]
45. Creatinine in urine [Biomonitoring Methods, 2010]
46. Hochleistungflüssigchromatographische Verfahren zur Bestimmung organischer Substanzen in biologischem Material [Biomonitoring Methods in German language, 2000]
47. N-Acetyltransferase 2 (Phänotypisierung: Coffein-Test) [Biomonitoring Methods in German language, 2004]
48. N-Acetyltransferase2 (Genotypisierung) [Biomonitoring Methods in German language, 2004]
49. Genotyping of NAT2: Sensitivity and specificity of the novel tagSNP rs1495741 with respect to the in vivo phenotype
50. c-Myc related SNP rs9642880[T], GSTM1 genotype and occupational exposure in urinary bladder cancer cases
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.